UMB Bank N A MO lessened its holdings in UnitedHealth Group Inc (NYSE:UNH) by 1.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 166,062 shares of the healthcare conglomerate’s stock after selling 2,418 shares during the period. UnitedHealth Group comprises 1.2% of UMB Bank N A MO’s holdings, making the stock its 14th biggest position. UMB Bank N A MO’s holdings in UnitedHealth Group were worth $36,610,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Capital International Investors raised its stake in shares of UnitedHealth Group by 399.3% during the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock worth $809,370,000 after acquiring an additional 3,304,902 shares in the last quarter. Jennison Associates LLC raised its stake in shares of UnitedHealth Group by 146.0% during the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after acquiring an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC raised its stake in shares of UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares in the last quarter. Finally, Parametric Portfolio Associates LLC raised its stake in shares of UnitedHealth Group by 77.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after acquiring an additional 1,562,661 shares in the last quarter. 85.65% of the stock is owned by hedge funds and other institutional investors.
In other news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders sold a total of 53,396 shares of company stock worth $12,262,067 over the last ninety days. Insiders own 0.89% of the company’s stock.
UNH has been the subject of several recent analyst reports. Cantor Fitzgerald reiterated a “buy” rating and set a $225.00 price objective on shares of UnitedHealth Group in a research note on Monday, November 27th. Jefferies Group reiterated a “buy” rating and set a $248.00 price objective on shares of UnitedHealth Group in a research note on Friday, December 1st. Deutsche Bank boosted their price objective on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, January 17th. Credit Suisse Group started coverage on shares of UnitedHealth Group in a research note on Thursday, November 2nd. They set an “outperform” rating and a $233.00 price target on the stock. Finally, Royal Bank of Canada upped their price target on shares of UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Two analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $243.22.
Shares of UnitedHealth Group Inc (UNH) opened at $230.16 on Friday. The company has a market cap of $222,720.00, a price-to-earnings ratio of 24.23, a PEG ratio of 1.32 and a beta of 0.70. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a twelve month low of $161.74 and a twelve month high of $250.79.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the prior year, the firm earned $2.11 EPS. sell-side analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.30%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.58%.
TRADEMARK VIOLATION WARNING: This piece was first posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://transcriptdaily.com/2018/02/25/umb-bank-n-a-mo-lowers-stake-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.